TRYVIO is a prescription medicine used to treat high blood pressure (hypertension) in adults who are taking other high blood pressure medicines and whose blood pressure is not well controlled.

TRYVIO is an endothelin receptor antagonist indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who …

Advise use of effective contraception before the start of TRYVIO, during treatment and for one month after stopping treatment. When pregnancy is detected, discontinue TRYVIO as soon as …

Apr 29, 2025 · Tryvio (aprocitentan) is a once-daily, dual oral ERA that may be used to treat high blood pressure that is not adequately controlled by other high blood pressure medications. It is …

Oct 17, 2025 · Find patient medical information for Tryvio (Aprocitentan) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Apr 17, 2025 · Tryvio (aprocitentan) is an endothelin receptor antagonist indicated for the treatment of high blood pressure (hypertension) in combination with other antihypertensive …

Mar 29, 2024 · Tryvio (aprocitentan), made by pharmaceutical company Idorsia, is a once-daily oral medication that helps lower blood pressure in adults with uncontrolled high blood pressure.

Medscape - Resistant hypertension dosing for Tryvio (aprocitentan), frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and …

TRYVIO is an endothelin receptor antagonist indicated for the treatment of hypertension in combination with other antihypertensive drugs, to lower blood pressure in adult patients who …

Because of the risk of birth defects, aprocitentan is only available through a restricted program called the TRYVIO Risk Evaluation and Mitigation Strategy (REMS) (See REMS under Other …